Change Healthcare Inc.

Delisted

CIK 0001756497Large AcceleratedServices-Computer Processing & Data PreparationDelawareFY ends Mar 31

Period

FY 2022

Revenue

$3.48B

Net Income

$-57.39M

Total Assets

$9.93B

Equity

$3.28B

Shares Out

328.31M

Op. Cash Flow

$696.88M

Business

Change Healthcare Inc. is a former operating company in Computer Processing & Data Preparation, incorporated in Delaware. Securities are no longer actively traded on a major U.S. exchange.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31
Total revenue	3,481	3,090	197	—	—
Cost of operations (exclusive of depreciation and amortization below)	1,415	1,335	71	—	—
Research and development	278	227	12	—	—
Sales, marketing, general and administrative	735	687	40	1	180,000
Customer postage	220	197	13	—	—
Depreciation and amortization	682	591	31	—	—
Accretion and changes in estimate with related parties, net	15	13	16	—	—
Gain on sale of businesses	—	−59	—	—	—
Tax Receivable Agreement charges	—	—	165	—	—
Goodwill impairment charge	—	—	561	—	—
Total operating expenses	3,344	2,990	908	1	180,000
Operating income (loss)	137	100	−711	−1	−180,000
Interest expense, net	234	245	17	—	—
Loss on extinguishment of debt	4	9	—	—	—
Loss from Equity Method Investment in the Joint Venture	—	—	381	70	59
(Gain) loss on forward purchase contract	—	—	−16	—	—
Other, net	5	−7	−2	−1	—
Total non-operating (income) expense	243	247	380	69	58
Income (loss) before income tax provision (benefit)	−106	−147	−1,091	−71	−59
Income tax provision (benefit)	−49	−35	−143	−19	−120
Net income (loss)	−57	−112	−948	−52	61
Basic and diluted (per share)	−0.18	−0.35	−6.92	−0.69	—
Basic and diluted (shares)	324	321	137	76	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-05-31	FY 2020 2020-04-30	FY 2020 2020-03-31
Cash & cash equivalents	252	113	—	—	410
Accounts receivable, net	720	733	—	—	740
Contract assets, net	163	133	—	—	133
Prepaid expenses and other current assets	178	140	—	—	118
Total current assets	1,313	1,119	—	—	1,401
Property and equipment, net	141	174	—	—	206
Operating lease right-of-use assets, net	66	93	—	112	—
Goodwill	4,113	4,109	99	—	3,795
Intangible assets, net	3,700	4,187	—	—	4,366
Other noncurrent assets, net	600	430	—	—	192
Total assets	9,932	10,113	—	—	10,107
Accounts payable	104	57	—	—	68
Accrued expenses	462	484	—	—	390
Deferred revenue	469	437	—	—	302
Due to related parties, net	13	11	—	—	20
Current portion of long-term debt	10	27	—	—	279
Current portion of operating lease liabilities	22	31	—	—	—
Total current liabilities	1,080	1,047	—	—	1,060
Long-term debt, excluding current portion	4,580	4,735	—	—	4,710
Long-term operating lease liabilities	52	75	—	—	—
Deferred income tax liabilities	564	605	—	—	616
Tax receivable agreement obligations due to related parties	105	103	—	—	178
Tax receivable agreement obligations	203	229	—	—	165
Other long-term liabilities	73	66	—	—	93
Total liabilities	6,656	6,860	—	—	6,822
Commitments and contingencies	—	—	—	—	—
Common Stock (par value, $0.001), 9,000,000,000 and 9,000,000,000 shares authorized and 313,131,714 and 306,796,076 shares issued and outstanding at March 31, 2022 and March 31, 2021, respectively	313,000	307,000	—	—	303,000
Preferred stock (par value, $0.001), 900,000,000 shares authorized and no shares issued and outstanding at both March 31, 2022 and March 31, 2021	—	—	—	—	—
Additional paid-in capital	4,341	4,283	—	—	4,223
Accumulated other comprehensive income (loss)	35	11	—	—	−7
Accumulated deficit	−1,100	−1,043	—	—	−930
Total stockholders' equity	3,276	3,252	—	—	3,285
Total liabilities and stockholders' equity	9,932	10,113	—	—	10,107

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31
Amortization of capitalized software developed for sale	4	1	—	—	—
Accretion and changes in estimate, net	25	12	16	—	—
Equity compensation	96	59	2	—	—
Deferred income tax expense (benefit)	−49	−50	−144	−19	—
Amortization of debt discount and issuance costs	31	33	2	—	—
Non-cash lease expense	27	29	—	—	—
Other, net	18	8	−1	−661,000	—
Accounts receivable, net	12	−6	−21	—	—
Contract assets, net	−26	158,000	—	—	—
Prepaid expenses and other assets	−83	−88	−6	14	—
Accounts payable	35	−21	8	—	—
Accrued expenses and other liabilities	−61	14	−195	−125,000	−524,000
Deferred revenue	40	166	11	—	—
Due to the Joint Venture, net	—	—	1	−10	16
Net cash provided by (used in) operating activities	697	586	−154	3	—
Capitalized expenditures	−276	−246	−13	—	—
Acquisitions, net of cash acquired	—	−439	331	—	—
Proceeds from sale of businesses	—	116	—	—	—
Investment in the Joint Venture	—	—	−611	—	—
Investment in debt and equity securities of the Joint Venture	—	—	−279	—	—
Other, net	−663,000	2	7	7	—
Net cash provided by (used in) investing activities	−277	−568	−565	7	171,000
Payments on Term Loan Facility	−180	−315	—	—	—
Payments under tax receivable agreements	−22	−21	—	—	—
Receipts (payments) on derivative instruments	−23	−30	−890,000	—	—
Employee tax withholding on vesting of equity compensation awards	−38	−4	—	—	—
Payments on deferred financing obligations	−11	−20	—	—	—
Payment of senior amortizing notes	−16	−16	−11	—	—
Proceeds from exercise of equity awards	9	18	—	—	—
Payments on Revolving Facility	—	−250	—	—	—
Proceeds from Revolving Facility	—	—	250	—	—
Proceeds from issuance of Senior Notes	—	325	—	—	—
Proceeds from initial public offering, net of issuance costs	—	—	609	—	—
Proceeds from issuance of equity component of tangible equity units, net of issuance costs	—	—	233	—	—
Proceeds from issuance of debt component of tangible equity units	—	—	47	—	—
Other, net	−468,000	−7	−1	−7	—
Net cash provided by (used in) financing activities	−281	−319	1,126	−7	−171,000
Effect of exchange rate changes on cash and cash equivalents	165,000	3	16,000	—	—
Net increase (decrease) in cash and cash equivalents	139	−297	407	3	—
Cash paid for interest	224	240	266	—	—
Cash paid for income taxes	8	11	−714,000	—	16
Operating cash flows	37	41	—	—	—
Financing cash flows	468,000	642,000	—	—	—
Investment in the Joint Venture	—	—	5	1	5
Dividend receivable	—	—	−5	1	−5
Investment in the Joint Venture	—	—	14	−2	11
Additional paid in capital	—	—	−11	−6	−7
Accumulated other comprehensive income	—	—	−3	−8	−3
Property and equipment, net	9	3	5	—	—
Other noncurrent assets, net	31	25	14	—	—
Intangible assets, net	3	1	3	—	—
Accounts payable	−25	−11	−10	—	—
Accrued expenses	−18	−18	−12	—	—
Operating Leases	3	16	—	—	—
Finance Leases	—	363,000	—	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Change Healthcare Inc.'s CIK number?

Change Healthcare Inc.'s SEC CIK number is 0001756497 (1756497). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Change Healthcare Inc.'s SEC filings?

All of Change Healthcare Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

Look up any company's CIK number →